Position in RVMD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$33,481,916
+$30,151,980 QoQ
Shares Held
178,780
+422.1% QoQ
Ownership
0.083%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#107
of 675 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in RVMD Over Time
Shares Held
Position Value (USD)
Derivatives in RVMD
reported options exposure · as of Dec 31, 2025CallValue
$0
CallShares
0
PutValue
$509,760
PutShares
6,400
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,528,481 across 417 Biotechnology names. RVMD ranks #6 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
This page
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in RVMD
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $33,481,916 | 178,780 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $3,329,936 | 34,241 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $1,045,005 | 13,120 | Shares | Defined | 2026-02-13 | |
| 2025-12-31 | $509,760 | 6,400 | Put | Defined | 2026-02-13 | |
| 2025-09-30 | $298,880 | 6,400 | Put | Defined | 2025-11-13 | |
| 2025-09-30 | $416,562 | 8,920 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $281,073 | 7,640 | Shares | Defined | 2025-08-14 | |
| 2025-06-30 | $235,456 | 6,400 | Put | Defined | 2025-08-14 | |
| 2025-03-31 | $3,269,738 | 92,470 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $3,863,422 | 88,327 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $2,638,098 | 58,172 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $2,145,144 | 55,273 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,411,736 | 43,802 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $1,146,223 | 39,966 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $1,733,984 | 62,644 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,639,286 | 98,665 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $1,546,869 | 71,416 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $43,018 | 1,806 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $71,425 | 3,622 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $63,126 | 3,239 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $644,610 | 25,269 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,163,355 | 46,220 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,618,521 | 58,834 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $537,008 | 16,919 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $561,570 | 12,240 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $3,258,018 | 82,294 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $1,624,359 | 46,677 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $1,258,884 | 39,876 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $184,767 | 8,433 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||